3Bakfis GL,Bell PS,Fonseca V,et al.The rationale and design of the giyeemic effects in diabetes mellitus[J].J Diabetes Complications, 2005, 19 : 74.
4Macullaugh PA,Nowad RM,Mccord J,et al.B type natiuretic peptide in the emergency diagnosis of heart failure:analysis from breathing not properly Multinational[J].Study Circulation,2002,106(4):416-422.
5Groenning BA,Nilsson JC,Sondergoard L,et al.Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations[J].Eur J Heart Fail,2001,3(1):699-708.
6Klinge R,Hystad M,Kjekshus J,et al.An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure[J].Scand J Clin Lab Invest.1998,58(8):683.
7Peter P, Liu M D. Cardiorenal syndrome in heart failure:a cardiolo- gist' s perspective [ J ]. Can J Cardiol, 2008,24 ( Suppl B ) : 25 B- 29B.
8Metra M, Nodari S, Parrinello G,et al. Worsening renal function in patients hospitalized for acute heart failure: clinical implications and prognostic significance [ J ]. Eur J Heart Fail, 2008,10 ( 2 ) : 188-195.
9Gottlieb S S, Abraham W T, Butler J, et al. The prognostic impor- tance of different definitions of worsening renal function in conges- tire heart failure [ J ]. J Card Fail,2002,8 ( 3 ) : 136-141.
10Blankstein R, Bakris G L. Renal hemodynamic changes in heart failure [ J ]. Heart Fail Clin, 2008,4 ( 4 ) :411-423.
